MARKET

XCUR

XCUR

Exicure Inc
NASDAQ
11.86
+0.42
+3.67%
After Hours: 11.63 -0.23 -1.94% 16:37 05/12 EDT
OPEN
11.44
PREV CLOSE
11.44
HIGH
11.86
LOW
11.22
VOLUME
9.52K
TURNOVER
--
52 WEEK HIGH
36.00
52 WEEK LOW
1.440
MARKET CAP
74.93M
P/E (TTM)
-2.4980
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XCUR last week (0505-0509)?
Weekly Report · 18h ago
Exicure Enters Convertible Bond Agreement with Subsidiary
TipRanks · 6d ago
Exicure completes patient enrollment in GPC-100 trial
TipRanks · 05/05 13:26
EXICURE INC: TOPLINE RESULTS EXPECTED H2 2025
Reuters · 05/05 12:00
EXICURE COMPLETES PATIENT ENROLLMENT IN PHASE 2 STUDY OF GPC-100 FOR STEM CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANT
Reuters · 05/05 12:00
Weekly Report: what happened at XCUR last week (0428-0502)?
Weekly Report · 05/05 11:37
Weekly Report: what happened at XCUR last week (0421-0425)?
Weekly Report · 04/28 11:47
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 04/21 17:05
More
About XCUR
More
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Recently
Symbol
Price
%Change

Webull offers Exicure Inc stock information, including NASDAQ: XCUR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XCUR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XCUR stock methods without spending real money on the virtual paper trading platform.